Mette M Rosenkilde

Mette M Rosenkilde has a long and varied work experience. Mette M began their career in 1999 as an Assistant Professor at the Faculty of Health and Medical Sciences at the University of Copenhagen (UCPH). Mette M was then promoted to Associate Professor and then to Professor in Basic and Translational Pharmacology. In 2003, they became a Consultant for 7TM Pharma. In 2007, they became a Professor at the Danish Society for Pharmacology and Co-Founder of INAGEN. In 2017, they Co-Founded Antag Therapeutics and Synklino, and became a Member of the Board of Directors for both companies. In 2018, they became a Member of the Board of Directors and Co-Founder of Bainan Biotech. In 2020, they became a Member of the Board of Directors for Independent Research Fund Denmark.

Mette M Rosenkilde began their educational journey in 1986 when they attended Aurehøj gymnasium for high school. Mette M then attended Københavns Universitet - University of Copenhagen from 1989 to 1996, earning a Doctor of Medicine - MD in Medicine. Mette M then continued their studies at Københavns Universitet - University of Copenhagen from 1996 to 2000, earning a PhD in Molecular Pharmacology. In 2020, they earned a Board Certificate from Board Company.